Modeling of adsorption isotherms of reactive red RR-120 on spirulina platensis by statistical physics formalism involving interaction effect between adsorbate molecules

Repurposing Anticancer Drugs Targeting the MAPK/ERK Signaling Pathway for the Treatment of Respiratory Virus Infections

Respiratory virus infections remain a significant challenge to human health and the social economy. The symptoms range from mild rhinitis and nasal congestion to severe lower respiratory tract dysfunction and even mortality. The efficacy of therapeutic drugs targeting respiratory viruses varies, depending upon infection time and the drug resistance engendered by a high frequency of viral genome mutations, necessitating the development of new strategies. The MAPK/ERK pathway that was well delineated in the 1980s represents a classical signaling cascade, essential for cell proliferation, survival, and differentiation. Since this pathway is constitutively activated in many cancers by oncogenes, several drugs inhibiting Raf/MEK/ERK have been developed and currently used in anticancer treatment. Two decades ago, it was reported that viruses such as HIV and influenza viruses could exploit the host cellular MAPK/ERK pathway for their replication. Thus, it would be feasible to repurpose this category of the pathway inhibitors for the treatment of respiratory viral infections. The advantage is that the host genes are not easy to mutate such that the drug resistance rarely occurs during short-period treatment of viruses. Therefore, in this review we will summarize the research progress on the role of the MAPK/ERK pathway in respiratory virus amplification and discuss the potential of the pathway inhibitors (MEK inhibitors) in the treatment of respiratory viral infections.

Development of adsorbent rigid structure based on Spirulina sp./chitosan bioblends coatings for dye adsorption in fixed bed column

The glass particles were coated with Spirulina sp. LEB-18 and bioblends of Spirulina sp. LEB-18/chitosan by casting technique and, afterward, it was verified its potential as adsorbents for basic and acid dyes. Nine Spirulina sp. suspensions with different components were used to coat the glass particles, and in the best condition of coating were prepared the bioblends with chitosan. The coated glass particles with Spirulina sp. and its bioblends with chitosan were applied in adsorption of the allura red (acid) and methylene blue (basic) dyes in a batch operation evaluate the pH effect, and a fixed bed column operation, being evaluated to the removal percentage and adsorption capacity of the column. The glass particles coated with Spirulina sp. applied in batch adsorption showed the highest removal percentages for allura red dye (35 to 45%) at pH 4.0, and for methylene blue dye (35 to 80%) at pH 6.0 and 8.0. In fixed bed column using glass particles coated with bioblends were reached the amount dye of 54.2 mg of adsorbed allura red dye and 60.2 mg of the of adsorbed methylene blue dye, respectively. Moreover, it was found good dye adsorption capacities, around 89 mg g^-1, for both dyes, in acidic and basic pH values. Based on these results, these bioblends coated glass particles can be applied as an adsorbent for different types of dyes in adsorption column.